AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome

Journal of Investigative Dermatology

Volumn 132, Issue 6, 2012, Pages 1689-1697

  Hoshimoto, Sojun ^a   Kuo, Christine T ^a   Chong, Kelly K ^a   Takeshima, Teh Ling ^a   Takei, Yoshiki ^a   Li, Michelle W ^a   Huang, Sharon K ^a   Sim, Myung Shin ^a   Morton, Donald L ^a   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENT IN MELANOMA 1 PROTEIN; CRYSTALLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; EPIGENETICS; FEMALE; HUMAN; HUMAN TISSUE; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN METHYLATION; TISSUE SECTION;

EID: 84862824075     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.36     Document Type: Article

References (58)

1. Aravind P, Wistow G, Sharma Y et al. (2008) Exploring the limits of sequence and structure in a variant betagamma-crystallin domain of the protein absent in melanoma-1 (AIM1). J Mol Biol 381:509-18
2. Bahrami S, Cheng L, Wang M et al. (2007) Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis. Mod Pathol 20:821-7 (Pubitemid 47077273)
3. Brouha B, Schustak J, Badge RM et al. (2003) Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 100:5280-5 (Pubitemid 36542696)
4. Chalitchagorn K, Shuangshoti S, Hourpai N et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23:8841-6 (Pubitemid 39593298)
5. Cho NY, Kim BH, Choi M et al. (2007) Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. J Pathol 211:269-77 (Pubitemid 46172702)
6. Coolen MW, Statham AL, Gardiner-Garden M et al. (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative highthroughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35:e119
7. Daskalos A, Nikolaidis G, Xinarianos G et al. (2009) Hypomethylation of retrotransposable elements correlates with genomic instability in nonsmall cell lung cancer. Int J Cancer 124:81-7
8. de Maat MF, Narita N, Benard A et al. (2010a) Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. Am J Pathol 177:2347-56
9. de Maat MF, Umetani N, Sunami E et al. (2007a) Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles. Mol Cancer Res 5:461-71 (Pubitemid 46903955)
10. de Maat MF, van de Velde CJ, Benard A et al. (2010b) Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 16:2811-8
11. de Maat MF, van de Velde CJ, Umetani N et al. (2007b) Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer. J Clin Oncol 25:4887-94 (Pubitemid 350220418)
12. de Maat MF, van de Velde CJ, van der Werff MP et al. (2008) Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol 26:2327-35
13. Eden A, Gaudet F, Waghmare A et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455 (Pubitemid 36444319)
14. Estecio MR, Gallegos J, Vallot C et al. (2010) Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res 20:1369-82
15. Estecio MR, Gharibyan V, Shen L et al. (2007) LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS ONE 2:e399
16. Fujiwara Y, Chi DD, Wang H et al. (1999) Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res 59:1567-71 (Pubitemid 29160127)
17. Furuta J, Umebayashi Y, Miyamoto K et al. (2004) Promoter methylation profiling of 30 genes in human malignant melanoma. Cancer Sci 95:962-8 (Pubitemid 40089588)
18. Gaudet F, Hodgson JG, Eden A et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300:489-92 (Pubitemid 36444330)
19. Haqq C, Nosrati M, Sudilovsky D et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102:6092-7 (Pubitemid 40594260)
20. Hoon DS, Spugnardi M, Kuo C et al. (2004) Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 23:4014-22 (Pubitemid 38747930)
21. Iqbal J, Kucuk C, Deleeuw RJ et al. (2009) Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 23:1139-51
22. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-92 (Pubitemid 46273572)
23. Koyanagi K, Mori T, O'Day SJ et al. (2006a) Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res 66:6111-7
24. Koyanagi K, O'Day SJ, Boasberg P et al. (2010) Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin Cancer Res 16:2402-8
25. Koyanagi K, O'Day SJ, Gonzalez R et al. (2006b) Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res 12:1137-43 (Pubitemid 43342501)
26. Lander ES, Linton LM, Birren B et al. (2001) Initial sequencing and analysis of the human genome. Nature 409:860-921 (Pubitemid 32165345)
27. Lee HS, Kim BH, Cho NY et al. (2009) Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 15:812-20
28. McShane LM, Altman DG, Sauerbrei W et al. (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23:9067-72
29. Minakami R, Kurose K, Etoh K et al. (1992) Identification of an internal ciselement essential for the human L1 transcription and a nuclear factor(s) binding to the element. Nucleic Acids Res 20:3139-45
30. Mirmohammadsadegh A, Marini A, Nambiar S et al. (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546-52 (Pubitemid 44085609)
31. Mori T, O'Day SJ, Umetani N et al. (2005) Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. J Clin Oncol 23:9351-8
32. Mungall AJ, Palmer SA, Sims SK et al. (2003) The DNA sequence and analysis of human chromosome 6. Nature 425:805-11 (Pubitemid 37351459)
33. Narita N, Tanemura A, Murali R et al. (2009) Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene 28:3058-68
34. Ogino S, Kawasaki T, Nosho K et al. (2008a) LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int J Cancer 122:2767-73 (Pubitemid 351631379)
35. Ogino S, Nosho K, Kirkner GJ et al. (2008b) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734-8
36. Ostertag EM, Kazazian Jr HH (2001) Biology of mammalian L1 retrotransposons. Annu Rev Genet 35:501-38 (Pubitemid 34032985)
37. Ovchinnikov I, Rubin A, Swergold GD (2002) Tracing the LINEs of human evolution. Proc Natl Acad Sci USA 99:10522-7
38. Patino WD, Susa J (2008) Epigenetics of cutaneous melanoma. Adv Dermatol 24:59-70
39. Pattamadilok J, Huapai N, Rattanatanyong P et al. (2008) LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer 18:711-7 (Pubitemid 352020191)
40. Poage GM, Houseman EA, Christensen BC et al. (2011) Global hypomethylation identifies loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res 17:3579-89
41. Radpour R, Haghighi MM, Fan AX et al. (2008) High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res 6:1702-9
42. Ray ME, Wistow G, Su YA et al. (1997) AIM1, a novel non-lens member of the betagamma-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci USA 94:3229-34 (Pubitemid 27157293)
43. Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426-37
44. Scott AF, Schmeckpeper BJ, Abdelrazik M et al. (1987) Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics 1:113-25
45. Sigalotti L, Fratta E, Bidoli E et al. (2011) Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. J Transl Med 9:78
46. Stark M, Hayward N (2007) Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67:2632-42 (Pubitemid 46548950)
47. Sunami E, de Maat M, Vu A et al. (2011) LINE-1 hypomethylation during primary colon cancer progression. PLoS One 6:e18884
48. Sunami E, Vu AT, Nguyen SL et al. (2009) Analysis of methylated circulating DNA in cancer patients' blood. Methods Mol Biol 507:349-56
49. Takeuchi H, Morton DL, Kuo C et al. (2004) Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Oncol 22:2671-80 (Pubitemid 41103755)
50. Tanemura A, Terando AM, Sim MS et al. (2009) CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15:1801-7
51. Tellez CS, Shen L, Estecio MR et al. (2009) CpG island methylation profiling in human melanoma cell lines. Melanoma Res 19:146-55
52. Trent JM, Stanbridge EJ, McBride HL et al. (1990) Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247:568-71
53. Umetani N, de Maat MF, Mori T et al. (2005) Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase. Biochem Biophys Res Commun 329:219-23 (Pubitemid 40255443)
54. Umetani N, Kim J, Hiramatsu S et al. (2006) Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 52:1062-9 (Pubitemid 43794418)
55. van Hoesel AQ, van de Velde CJ, Kuppen PJ et al. (2011) Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer. Breast Cancer Res Treat 131:859-69
56. Worm J, Christensen C, Gronbaek K et al. (2004) Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23:5215-26 (Pubitemid 38980354)
57. Yang AS, Estecio MR, Doshi K et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32:e38
58. Yoshimura T, Nagahara M, Kuo C et al. (2011) Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment. Epigenetics 6:1001-11